Physician profile
Robert J Soiffer
NPI 1780653261
$143,392.16
in general payments reported to CMS, 2019-2025
15 companies · $24K in 2025
The $24K reported for 2025 was more than what 90% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $24K · 2021: $19K · 2022: $16K · 2023: $22K · 2024: $16K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $8,464 · Food and Beverage: $3,938 · Gift: $130 · Entertainment: $90.00 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,445.00 |
| Travel and Lodging | $8,463.82 |
| Food and Beverage | $3,938.16 |
| Gift | $130.00 |
| Entertainment | $90.00 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $48,650.00 | 2022-2025 | |
| Gilead Sciences, INC. | $22,317.29 | 2019-2021 | |
| Celgene Corporation | $21,750.00 | 2019-2021 | |
| National Marrow Donor Program | $15,078.07 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $10,214.73 | 2019-2025 | |
| Partner Therapeutics, INC. | $6,875.00 | 2020 | |
| Astellas Pharma Global Development | $6,820.00 | 2023-2024 | Xospata |
| Alexion Pharmaceuticals, INC. | $4,575.00 | 2020 | |
| Csl Behring | $2,935.00 | 2024 | |
| Medexus Pharma, INC. | $2,040.00 | 2024 | |
| Daiichi Sankyo INC. | $1,935.00 | 2022 | |
| Incyte Corporation | $109.89 | 2024 | Jakafi |
| Astrazeneca Pharmaceuticals Lp | $43.25 | 2025 | Enhertu |
| Regeneron Pharmaceuticals, INC. | $29.30 | 2019 | |
| Amgen INC. | $19.63 | 2024 | Blincyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Soiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.